PUBLIC CONTRACT · 2023
Pq/2901/2023 lenalidomida 25MG CP
- Contract value
- €1,869.00
- Signed on
- 25 November 2023
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 10696431PUBLISHED SUBJECT
PQ/2901/2023 LENALIDOMIDA 25MG CP
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Lisboa, Lisboa
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- EQYON HEALTHCARE SOLUTIONS, LDA · Tax ID 516338021
- Bidder
- SANDOZ FARMACÊUTICA, LDA. · Tax ID 506985261
- Bidder
- CELGENE - SOCIEDADE UNIPESSOAL LDA · Tax ID 507791690
- Bidder
- Mylan Lda. · Tax ID 502248793
- Bidder
- KRKA FARMACEUTICA · Tax ID 507981227
- Bidder
- PHARMAKERN PORTUGAL, LDA. · Tax ID 507002571
- Bidder
- Generis Farmacêutica, S.A. · Tax ID 508107997
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €1,869.00
- Procedure base price
- €307,660.08
- Total effective price
- Not reported on Portal BASE
- Publication date
- 2 May 2024
- Award date
- 11 November 2023
- Signing date
- 25 November 2023
- Performance period
- 31 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- 481/2023 - Acordo quadro para fornecimento de medicamentos diversos
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 6818598
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.